Pediatric ulcerative colitis: current treatment approaches including role of infliximab
Gia M Bradley, Maria Oliva-HemkerDivision of Pediatric Gastroenterology and Nutrition, Johns Hopkins University School of Medicine, Baltimore, MD, USAAbstract: Ulcerative colitis is a chronic inflammatory bowel disease that can lead to derangements in the growth, nutritional status, and psychosocial...
Guardado en:
Autores principales: | Bradley GM, Oliva-Hemker M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a01990c36f4f489e9e906b645fcc050e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Infliximab in ulcerative colitis
por: Avi Levin, et al.
Publicado: (2008) -
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
por: Viscido A, et al.
Publicado: (2019) -
Golimumab in unresponsive ulcerative colitis
por: Lippert E, et al.
Publicado: (2014) -
New and emerging treatments for ulcerative colitis: a focus on vedolizumab
por: Gledhill T, et al.
Publicado: (2013) -
Infliximab for the treatment of plaque psoriasis
por: Jennifer S Gall, et al.
Publicado: (2008)